Select Page

Opportunity Assessment

Life sciences investment analysis

Evaluating the attractiveness of investment opportunities in the life sciences—whether individual assets, multifaceted portfolios or entire companies—is a complex exercise that requires both instinct and precision: the instinct to recognize the scientific and clinical promise of an asset, envision the path to market, and anticipate the perceptions of customers, payers and end-users; the investment-grade precision to forecast commercial potential and support a clear decision.

Integrating depth in business, science and healthcare, Shift Health brings discerning instinct and data-driven precision to opportunity assessment. Our track record evaluating a spectrum of investment scenarios, therapy areas and asset classes across diverse and increasingly convergent sectors allows us to apply proven analytical frameworks that separate signals from the noise. We are adept at translating relevant evidence into dynamic and multivariate financial models that support sound valuations our clients can trust.

Opportunity Identification — Opportunity Evaluation — Financial Modeling